A study on role of magnetic resonance imaging in the evaluation of intracranial neoplastic lesions

Shekavva Halli; Vinod Hegde

doi:10.18203/2320-6012.ijrms20231779

Authors

Shekavva Halli Department of Radiodiagnosis, Srinivas Institute of Medical Sciences and Research Centre, Mangalore, Karnataka, India
Vinod Hegde Department of Radiodiagnosis, Srinivas Institute of Medical Sciences and Research Centre, Mangalore, Karnataka, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20231779

Keywords:

Intracranial neoplastic lesions, Magnetic resonance imaging, Tumours

Abstract

Background: Neoplastic central nervous system (CNS) lesions are a heterogeneous group of diseases with a variable outcome that reflects the precision of diagnosis and the delivery of optimal and specific treatment. CNS imaging has a pivotal role in directing management decisions. In the present study, cases of either clinically suspected intracranial neoplastic lesions or already diagnosed cases of neoplastic lesions were studied by cross sectional imaging of magnetic resonance imaging (MRI).

Methods: In this prospective study, 30 cases of intracranial neoplastic lesions were studied by 1.5T Siemens Essenza MR scanner over a period of 6 months. Imaging findings were evaluated and tabulated.

Results: Total 30 cases of in intracranial neoplastic lesions were studied aged between 12 to 87 years (17 men and 13 women). Most common presenting complaint was headache. Solitary lesions were present in 21 patients (70%) and multiple lesions in 9 patients (30%). 80% of the lesions were supratentorial, 13.3% were infratentorial and 6.6% were seen in both infra and supratentorial region. 76.6% were intra-axial and 23.3% were extra-axial. Metastasis were the most common neoplastic lesions; glial tumors are the second most common neoplastic lesions. Meningiomas were the most common benign tumors. Mass effect and perilesional edema were the most common associated findings.

Conclusions: MRI is the first line of investigation for diagnosis and evaluation of intracranial neoplastic lesions with reasonable degree of diagnostic accuracy. Neuroimaging in combination with clinical findings can be helpful in early diagnosis and timed intervention.

Metrics

Metrics Loading ...

References

Goyani BR, Ukani BV, Naik P, Bhagat H, Vadel MK, Sheth R. A Study on Role of Magnetic Resonance Imaging (Mri) In Intracranial Space Occupying Lesions. Nat J Med Res. 2015;15(1):18-21.

Bourgouin PM, Tampieri D, Grahovac SZ, Léger C, Del Carpio R, Melançon D. CT and MR imaging findings in adults with cerebellar medulloblastoma: comparison with findings in children. AJR Am J Roentgenol. 1992;159(3):609-12.

Tadmor R, Harwood-Nash DC, Scotti G, Savoiardo M, Musgrave MA, Fitz CR, et al. Intracranial neoplasms in children: the effect of computed tomography on age distribution. Radiology. 1982;145(2):371-3.

Abd-Ellah MK, Awad AI, Khalaf AAM, Hamed HFA. A review on brain tumor diagnosis from MRI images: Practical implications, key achievements, and lessons learned. Magn Reson Imaging. 2019;61:300-18.

Essig M, Anzalone N, Combs SE, Dorfler A, Lee SK, Picozzi P, et al. MR Imaging of Neoplastic Central Nervous System Lesions-Review and Recommendations for Current Practice. Am J Neuroradiol. 2012;33:803-17.

Leung D, Han X, Mikkelsen T, Nabors LB. Role of MRI in primary brain tumor evaluation. J Natl Compr Canc Netw. 2014;12(11):1561-8.

Sawlani V, Patel MD, Davies N, Flintham R, Wesolowski R, Ughratdar I, et al. Multiparametric MRI: practical approach and pictorial review of a useful tool in the evaluation of brain tumours and tumour-like lesions. Insights Imaging. 2020;11(1):84.

Razek AAKA. MR imaging of neoplastic and non-neoplastic lesions of the brain and spine in neurofibromatosis type I. Neurol Sci. 2018;39(5):821-7.

Mabray MC, Barajas RF, Cha S. Modern Brain Tumor Imaging. Brain Tumor Res Treat. 2015;3(1):8-23.

Snyder H, Robinson K, Shah D, Brennan R, Handrigan M. Signs and symptoms of patients with brain tumors presenting to the emergency department. J Emerg Med. 1993;11(3):253-8.

Essig M, Weber MA, von Tengg-Kobligk H, Knopp MV, Yuh WT, Giesel FL. Contrast-enhanced magnetic resonance imaging of central nervous system tumors: agents, mechanisms, and applications. Top Magn Reson Imaging. 2006;17(2):89-106.

Cenacchi G, Giangaspero F. Emerging tumor entities and variants of CNS neoplasms. J Neuropathol Exp Neurol. 2004;63(3):185-92.

Black WC. High-Dose MR in the Evaluation of Brain Metastases: Will Increased Detection Decrease Costs? AJNR. 1994;15:1062-4.

Zawadzki MB, Norman D, Newton TH, Kelly WM, Kjos B, Mills CM, et al. Magnetic Resonance of the Brain: The Optimal Screening Technique. Radiology. 1984;152:71-7.

Knopp MV, Runge VM, Essig M, Hartman M, Jansen O, Kirchin MA, et al. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology. 2004;230(1):55-64.

Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumours in adults. Lancet. 2003;361(9354):323-31.

Mayr NA, Yuh WTC, Muhonen MG. Cost-effectiveness of high dose MR contrast studies in the evaluation of brain metastases. AJNR Am J Neuroradiol. 1994;15:1053-61.